EIF4EBP1 and cancer: AZD2014 is a newer, second generation mTOR inhibitor that blocks activation of both mTORC1 (phosphorylation of 70S6K1 and 4EBP1) and mTORC2-mediated AKT Ser473 phosphorylation, and activates apoptosis in cancer cells [9].